Maintelyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Magnesium chloride hexahydrate supplies magnesium ions directly into the bloodstream. Magnesium is a key cofactor in many enzymatic reactions and helps stabilize cellular membranes. In the context of Maintelyte, it contributes to correcting low magnesium levels, supports cardiac and neuromuscular function, and works together with other electrolytes to re‑establish normal extracellular fluid composition.

The dose of Maintelyte is individualized and set by the prescribing clinician based on the patient’s current fluid status, electrolyte laboratory results, underlying medical conditions and the clinical goal (e.g., maintenance versus rapid replacement). No fixed dosing regimen is provided; the healthcare professional calculates the volume and rate required for each specific case.

Safety data for Maintelyte in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should assess the clinical need carefully and consider alternative therapies if appropriate.

To order Maintelyte, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Maintelyte combines magnesium, potassium, sodium, chloride, glucose and sodium acetate in a single formulation, offering a broader electrolyte profile than many standard isotonic saline solutions that contain only sodium and chloride. This makes it suitable for patients who need simultaneous replacement of multiple electrolytes and an energy substrate, whereas simpler solutions may require additional supplements.

Maintelyte must be stored at 2‑8 °C in a refrigerator. Keep the container in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, inspect the vial for any particulate matter or discoloration and discard if the integrity is compromised.

Maintelyte is administered intravenously using aseptic technique. The solution is typically infused through a peripheral or central venous line, with the rate adjusted according to the patient’s clinical condition and laboratory values. Infusion sets with appropriate filters should be used, and the infusion site should be monitored for signs of irritation or infiltration.

Serious risks include severe hypermagnesemia or hyperkalemia, which can cause cardiac arrhythmias, and fluid overload leading to pulmonary edema. Allergic or anaphylactic reactions, although rare, require immediate medical attention. Continuous monitoring of electrolyte levels and patient vitals is essential to detect these complications early.

Maintelyte should be avoided in patients with known hypersensitivity to any of its components, as well as those with documented severe hypermagnesemia, hyperkalemia, or uncontrolled heart failure. Caution is also advised for individuals with severe renal impairment where electrolyte clearance is markedly reduced.